CreativeOne Wealth’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-169,974
Closed -$17K 1178
2025
Q4
$17K Buy
169,974
+69,962
+70% +$44.5K ﹤0.01% 1168
2025
Q3
$60.5K Sell
100,012
-4,201
-4% -$1.98K ﹤0.01% 1140
2025
Q2
$32.4K Buy
104,213
+53,800
+107% +$20.8K ﹤0.01% 1102
2025
Q1
$24.6K Buy
50,413
+28,701
+132% +$16.9K ﹤0.01% 1050
2024
Q4
$18.6K Buy
+21,712
New +$136K ﹤0.01% 1058

CreativeOne Wealth's APLT Position: Q1 2026 in Review

CreativeOne Wealth sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 169,974 shares — an estimated $17K sold.

CreativeOne Wealth first reported a position in APLT in Q4 2024 and held it in 5 quarters. The position peaked at $60.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • CreativeOne Wealth reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CreativeOne Wealth sold 169,974 Applied Therapeutics shares in Q1 2026, an estimated $17K.
  • CreativeOne Wealth first reported a position in Applied Therapeutics in Q4 2024 and held it in 5 quarters.
  • CreativeOne Wealth's Applied Therapeutics position peaked at $60.5K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.